cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Seelos Therapeutics Inc
19 own
18 watching
Current Price
$1.33
$-0.06
(-4.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
6.38M
52-Week High
52-Week High
398.39999
52-Week Low
52-Week Low
1.30000
Average Volume
Average Volume
0.08M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization6.38M
icon52-Week High398.39999
icon52-Week Low1.30000
iconAverage Volume0.08M
iconDividend Yield--
iconP/E Ratio--
What does the Seelos Therapeutics Inc do?
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company s lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
Read More
How much money does Seelos Therapeutics Inc make?
News & Events about Seelos Therapeutics Inc.
PR Newswire
1 year ago
Seelos Therapeutics to Present a Poster on SLS-009 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting Seelos Therapeutics to Present a Poster on SLS-009 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting PR Newswire NEW YORK, May 5, 2023...
PR Newswire
1 year ago
Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock PR Newswire NEW YORK, March 10, 2023 NEW YORK, March 10, 2023 /PRNewswire...
PR Newswire
1 year ago
Seelos Therapeutics to Present a Poster on SLS-004 at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit Seelos Therapeutics to Present a Poster on SLS-004 at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit PR Newswire NEW YORK, Feb. 10, 2023...
PR Newswire
1 year ago
Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event PR Newswire NEW YORK, Dec. 22, 2022 NEW YORK, Dec. 22, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq...
PR Newswire
1 year ago
Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 PR Newswire NEW YORK, Nov. 23, 2022 NEW YORK, Nov. 23, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Seelos Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Seelos Therapeutics Inc shares?
plus_minus_icon
How can I buy Seelos Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Seelos Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Seelos Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Seelos Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Seelos Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Seelos Therapeutics Inc?
plus_minus_icon
What percentage is Seelos Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Seelos Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.33
$-0.06
(-4.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00